Nintedanib

Results: 28



#Item
11J. Math. Biol:765–798 DOIs00285Mathematical Biology  Multiscale modelling and nonlinear simulation

J. Math. Biol:765–798 DOIs00285Mathematical Biology Multiscale modelling and nonlinear simulation

Add to Reading List

Source URL: www.mathcancer.org

Language: English - Date: 2013-12-07 13:44:24
12Nintedanib in lung cancer: Added benefit depends on disease severity

Nintedanib in lung cancer: Added benefit depends on disease severity

Add to Reading List

Source URL: medicalxpress.com

Language: English - Date: 2015-05-03 05:03:40
13ANGIOGENESIS IN THE METASTATIC PROCESS AN ULTRASTRUCTURAL STUDY Supervisors: Prof C Christophi, Dr V Muralidharan and Dr T Fifis Contact details: Ph: [removed]or[removed]Email: [removed] or muv@unime

ANGIOGENESIS IN THE METASTATIC PROCESS AN ULTRASTRUCTURAL STUDY Supervisors: Prof C Christophi, Dr V Muralidharan and Dr T Fifis Contact details: Ph: [removed]or[removed]Email: [removed] or muv@unime

Add to Reading List

Source URL: www.austinsurgery.unimelb.edu.au

Language: English - Date: 2011-09-21 11:01:14
14J. Math. Biol[removed]:765–798 DOI[removed]s00285[removed]Mathematical Biology  Multiscale modelling and nonlinear simulation

J. Math. Biol[removed]:765–798 DOI[removed]s00285[removed]Mathematical Biology Multiscale modelling and nonlinear simulation

Add to Reading List

Source URL: mathcancer.org

Language: English - Date: 2013-12-07 13:44:24
15

PDF Document

Add to Reading List

Source URL: mathcancer.org

Language: English - Date: 2013-12-07 13:46:18
16Cancer turns blood vessels over to its cause

Cancer turns blood vessels over to its cause

Add to Reading List

Source URL: medicalxpress.com

Language: English - Date: 2015-03-20 09:07:21
17PRIOR AUTHORIZATION POLICY Ofev® (nintedanib capsules Boehringer Ingelheim)  To initiate a Coverage Review, Call[removed]

PRIOR AUTHORIZATION POLICY Ofev® (nintedanib capsules Boehringer Ingelheim) To initiate a Coverage Review, Call[removed]

Add to Reading List

Source URL: statehealthplan.state.nc.us

Language: English - Date: 2014-11-24 08:41:21
18Reduction in Disease Progression with Nintedanib in the INPULSIS™ Trials Vincent Cottin,1 Hiroyuki Taniguchi,2 Harold R. Collard,3 Luca Richeldi,4 Susanne Stowasser,5 Inga Tschoepe,6 Rozsa Schlenker-Herceg,7 Ganesh Rag

Reduction in Disease Progression with Nintedanib in the INPULSIS™ Trials Vincent Cottin,1 Hiroyuki Taniguchi,2 Harold R. Collard,3 Luca Richeldi,4 Susanne Stowasser,5 Inga Tschoepe,6 Rozsa Schlenker-Herceg,7 Ganesh Rag

Add to Reading List

Source URL: www.boehringer-ingelheim.com

Language: English - Date: 2014-09-05 11:09:49
19Nintedanib (BIBF[removed]prevents TGF-β-induced pro-fibrotic effects in primary human lung myofibroblasts derived from patients with idiopathic pulmonary fibrosis Katrin E. Hostettler1,2, MD PhD, Eleni Papakonstantinou3,

Nintedanib (BIBF[removed]prevents TGF-β-induced pro-fibrotic effects in primary human lung myofibroblasts derived from patients with idiopathic pulmonary fibrosis Katrin E. Hostettler1,2, MD PhD, Eleni Papakonstantinou3,

Add to Reading List

Source URL: www.boehringer-ingelheim.com

Language: English - Date: 2014-09-07 03:42:42
20Sensitivity Analyses from the INPULSIS™ Trials of Nintedanib Martin Kolb,1 Harold R. Collard,2 Susanne Stowasser,3 Mannaïg Girard,4 Rozsa Schlenker-Herceg,5 Luca Richeldi6 McMaster University, Ontario, Canada; 2Univer

Sensitivity Analyses from the INPULSIS™ Trials of Nintedanib Martin Kolb,1 Harold R. Collard,2 Susanne Stowasser,3 Mannaïg Girard,4 Rozsa Schlenker-Herceg,5 Luca Richeldi6 McMaster University, Ontario, Canada; 2Univer

Add to Reading List

Source URL: www.boehringer-ingelheim.com

Language: English - Date: 2014-09-07 03:42:29